Jim Cramer - Mad Money
Levi Strauss & Co.
LEVI-N
BUY
Jan 29, 2025
It reported after the bell superb 12% YOY sales growth, strength in the Americas, Europe and direct to consumer channels. They beat gross margins, but due to higher expenses, they delivered a modest earnings beat. Their full-year forecast was a little mixed, but overall good.
(A Top Pick Jul 12/22, Down 2.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with LEVI is progressing well. We now recommend to trail up the stop from $13 to $15.
(A Top Pick Jul 12/22, Down 11.6%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with LEVI has triggered its stop at $15. To remain disciplined, we recommend covering the position at this time.
Today, it reported an earnings and sales beat, but shares fell 16%. They lowered their full-year gross margin outlook a lot, but didn't touch earnings guidance. Also, they forecast a sales decline around 8-12% this quarter.
Could benefit from the weight-loss drug boom, because those who take those drugs will need need jeans. But the company reported a weak quarter and cut guidance.
They just reported a minor sales miss but an earnings beat and cut their full-year revenue forecast though asserted their earnings would meet the midpoint of previous guidance. Europe and direct-to-consumer are strong, but Asian and America are weaker.
They delivered a solid quarter, sales strong with an earnings beat thanks to higher than expected margins. Guidance is unchanged. Shares are down 45% from highs last June, but showed life at today's close.
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.
It reported after the bell superb 12% YOY sales growth, strength in the Americas, Europe and direct to consumer channels. They beat gross margins, but due to higher expenses, they delivered a modest earnings beat. Their full-year forecast was a little mixed, but overall good.